Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,542 | -1,536 | -27,274 | 4,237 | 1,123 |
| Depreciation Amortization | 8,997 | 8,887 | 9,188 | 8,063 | 7,263 |
| Income taxes - deferred | -320 | -181 | 5,268 | 1,651 | -1,139 |
| Accounts receivable | -5,236 | -977 | -1,522 | -2,480 | 3,461 |
| Accounts payable and accrued liabilities | -232 | -183 | 1,608 | 264 | -483 |
| Other Working Capital | -5,359 | -4,236 | -12,276 | -4,857 | 1,120 |
| Other Operating Activity | 13,940 | 8,740 | 7,785 | 8,511 | 2,665 |
| Operating Cash Flow | $248 | $10,514 | $-17,223 | $15,389 | $14,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,492 | -2,918 | -3,370 | -5,279 | -3,671 |
| Net Acquisitions | N/A | N/A | N/A | -40,553 | N/A |
| Purchase Of Investment | -25,445 | -3,904 | N/A | -22,723 | -59,917 |
| Sale Of Investment | 26,000 | N/A | 9,600 | 43,317 | 54,522 |
| Investing Cash Flow | $-2,937 | $-6,822 | $6,230 | $-25,238 | $-9,066 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 10,000 | 0 |
| Debt Issued | N/A | 29,664 | N/A | N/A | N/A |
| Common Stock Issued | 1,216 | 1,252 | 1,246 | 3,128 | 1,615 |
| Other Financing Activity | -4,166 | -12,510 | -1,621 | -2,901 | -6,263 |
| Financing Cash Flow | $-2,950 | $18,406 | $-375 | $10,227 | $-4,648 |
| Exchange Rate Effect | 335 | 323 | -787 | -10 | 128 |
| Beginning Cash Position | 41,419 | 18,998 | 31,153 | 30,785 | 30,361 |
| End Cash Position | 36,115 | 41,419 | 18,998 | 31,153 | 30,785 |
| Net Cash Flow | $-5,304 | $22,421 | $-12,155 | $368 | $424 |
| Free Cash Flow | |||||
| Operating Cash Flow | 248 | 10,514 | -17,223 | 15,389 | 14,010 |
| Capital Expenditure | -3,492 | -2,918 | -3,370 | -5,279 | -3,671 |
| Free Cash Flow | -3,244 | 7,596 | -20,593 | 10,110 | 10,339 |